Last updated on August 2019

Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus


Brief description of study

The purpose of the study is to assess the efficacy and safety of 4 doses of cenerimod versus placebo in adult subjects with systemic lupus erythematosus (SLE).

Detailed Study Description

This is a Phase 2b, multicenter, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of 4 doses of cenerimod versus placebo in adult subjects with moderately to severely active, autoantibody-positive systemic lupus erythematosus (SLE).

Approximately 500 adult subjects with SLE will be randomized in a 1:1:1:1:1 ratio to placebo, 0.5, 1, 2, or 4 mg o.d. of cenerimod, in addition to background SLE therapy.

Clinical Study Identifier: NCT03742037

Find a site near you

Start Over

Desert Medical Advances

Palm Desert, CA United States
  Connect »

Robert W Levin MD PA

Clearwater, FL United States
  Connect »

San Marcus Research Clinic

Miami Lakes, FL United States
  Connect »

Millennium Research

Ormond Beach, FL United States
  Connect »

Institute of Arthritis Research

Idaho Falls, ID United States
  Connect »

Innovative Health Research

Las Vegas, NV United States
  Connect »

Paramount Medical Research and Consulting

Middleburg Heights, OH United States
  Connect »

Accurate Clinical Research

Houston, TX United States
  Connect »

Sun Research Institute

San Antonio, TX United States
  Connect »

Accurate Clinical Management

Stafford, TX United States
  Connect »

CCR Pardubice

Pardubice, Czechia
  Connect »

Hopital Lapeyronie

Montpellier, France
  Connect »

Medicore

Tbilisi, Georgia
  Connect »

L da Mag nklinika

Zalaegerszeg, Hungary
  Connect »

City Clinical Hospital #15

Moscow, Russian Federation
  Connect »

Medical Center

Novosibirsk, Russian Federation
  Connect »

Hopital Lapeyronie

Montpellier, France
  Connect »